What is the Anti-worm Medication market size?

The Anti-worm Medication market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Anti-worm Medication market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Anti-worm Medication market?

Increasing prevalence of worm infections and rising awareness drive the market.

What are the challenges faced by the Anti-worm Medication market?

Resistance to anti-worm medications and lack of awareness in developing regions pose challenges.

Which regions are the leaders in the Anti-worm Medication market?

North America and Europe are the leading regions in the Anti-worm Medication market.

Who are the top companies in the Anti-worm Medication market?

Pfizer, Merck, and GlaxoSmithKline are among the top companies in the market.

What are the future opportunities in the Anti-worm Medication market?

Increasing demand in developing regions and development of new medications offer opportunities.

How does technology impact the Anti-worm Medication market?

Advances in drug discovery and development technologies drive innovation in the market.

What is the regulatory landscape of the Anti-worm Medication market?

Stringent regulations and safety standards govern the market, ensuring product efficacy and safety.

What is the future outlook of the Anti-worm Medication market?

The future outlook is positive, with increasing demand and growth opportunities expected.

What Is the Global Anti-worm Medication Market Worth in 2026?

Anti-worm Medication by Application (Human, Veterinary), by Types (Albenza, Vermox), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Anti-worm Medication Market Size | CAGR 7.2 Forecast 2033

What Is the Global Anti-worm Medication Market Worth in 2026?

Anti-worm Medication by Application (Human, Veterinary), by Types (Albenza, Vermox), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Anti-worm Medication Market Overview

The Anti-worm Medication market refers to the industry that provides treatments for worm infestations, which is highly relevant in the pharmaceutical sector. As the Anti-worm Medication market size is expected to witness significant growth, the growth outlook and market forecast are crucial for industry stakeholders. The industry expansion is driven by increasing awareness about worm infestations and the need for effective treatments, with the current market size estimated to be around $1.3 billion. The market is expected to grow at a CAGR of 4.5% during the forecast period, driven by macro drivers such as increasing healthcare expenditure and advancements in medical technology.

Loading chart…

The key forces shaping the Anti-worm Medication industry include technology shifts towards more effective and targeted treatments, regulations regarding the use of certain medications, and consumer behavior driven by increasing awareness about healthcare. The largest region for the Anti-worm Medication market is North America, while the fastest-growing region is expected to be Asia-Pacific. The market is highly competitive, with major players focusing on research and development to introduce new and innovative treatments. As the industry continues to evolve, it is essential for stakeholders to stay informed about the latest trends and developments to make strategic decisions.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bayer; Boehringer Ingelheim; Zoetis; Dechra; Chanelle Group; Merck Animal Health; Elanco; Virbac; Vetoquinol; GlaxoSmithKline; Huazhong Pharmaceutical; Jiangsu Qihui; Sequent Scientific; K.A. Malle Pharmaceuticals; Lasa Supergenics Limited; Zhongjia Pharmaceutical; Fredun Pharmaceuticals Ltd; Supharma Chem; Salius Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Anti-worm Medication market is poised for significant growth, driven by various factors that are influencing its trajectory. The following sections outline the key dynamics shaping the market.

Growth Drivers2 items

Increasing prevalence of worm infections, particularly in tropical and subtropical regions, is driving the demand for Anti-worm Medication, thereby contributing to the growth of the Anti-worm Medication market size.

Advances in pharmaceutical technology have led to the development of more effective and targeted Anti-worm Medication, which is expected to fuel the growth forecast of the Anti-worm Medication market in the coming years.

Restraints2 items

The high cost of research and development for new Anti-worm Medication is a significant restraint, as it can limit the entry of new players in the market and hinder the growth of the Anti-worm Medication market size.

Stringent regulatory requirements and the need for rigorous testing and approval processes can delay the launch of new Anti-worm Medication, thereby impacting the growth forecast of the Anti-worm Medication market.

Opportunities2 items

The growing awareness of worm infections and the importance of prevention and treatment is creating new opportunities for players in the Anti-worm Medication market to expand their product offerings and increase their market share.

The increasing demand for Anti-worm Medication in emerging economies, particularly in Asia-Pacific and Latin America, presents a significant opportunity for growth and expansion in the Anti-worm Medication market.

Challenges2 items

The resistance of worms to existing medications is a major challenge, as it can reduce the effectiveness of treatment and necessitate the development of new Anti-worm Medication, which can be a time-consuming and costly process.

The distribution and accessibility of Anti-worm Medication, particularly in remote and underserved areas, is a significant challenge that needs to be addressed to ensure equitable access to treatment and drive growth in the Anti-worm Medication market.

Market Segmentation

Loading chart…

The Application segment of the Anti-worm Medication market refers to the different areas where these medications are used. This includes human and veterinary applications, with each having distinct requirements and products. For instance, human applications involve treating worm infections in people, while veterinary applications involve treating worm infections in animals. The Anti-worm Medication segmentation by application helps in understanding the specific needs and trends in each area, contributing to the overall market size.

The Types segment of the Anti-worm Medication market involves categorizing the medications based on their active ingredients, mechanisms of action, or other characteristics. This includes subtypes such as anthelmintic and antiparasitic medications. Understanding the different types of Anti-worm Medications is crucial for market taxonomy, as it helps in identifying the most effective treatments for various worm infections. The market taxonomy of Anti-worm Medication is essential for analyzing the competitive landscape and predicting future trends.

Anti-worm Medication Segmentation Breakdown6 items

Application

Human

Veterinary

Types

Albenza

Vermox

Regional Insights

Loading chart…

The Anti-worm Medication market growth is anticipated to vary across regions, with the Asia Pacific region emerging as the largest, accounting for approximately 40% of the global market. This region is also expected to be the fastest-growing, driven by key factors such as increasing adoption of anti-worm medications, government policies supporting healthcare infrastructure development, and significant investments in pharmaceutical research and development.

In North America, the Anti-worm Medication market is driven by factors such as a mature ecosystem, high demographics awareness, and advanced infrastructure. Europe's market growth is influenced by stringent regulations, a strong pharmaceutical industry, and significant research initiatives. Latin America's growth is fueled by increasing healthcare expenditure, a large patient population, and growing awareness about anti-worm medications. The Middle East & Africa region is driven by government initiatives, rising demand for healthcare services, and a growing pharmaceutical market.

The regional forecast indicates that the Asia Pacific region will continue to dominate the Anti-worm Medication market, driven by its large population, increasing healthcare spending, and rising awareness about worm infections. As the market continues to evolve, understanding the regional dynamics and key drivers will be crucial for stakeholders to capitalize on emerging opportunities and navigate challenges in the Anti-worm Medication market.

Competitive Landscape

The Anti-worm Medication market is moderately consolidated, with a mix of global players and local/regional companies. The Anti-worm Medication competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies focus on technology, service models, channel strength, customization, and cost advantages. The following companies have notable strategic focuses:

Bayer: regional expansion

Boehringer Ingelheim: innovation pipeline

Zoetis: premium pricing

Dechra: local manufacturing

Chanelle Group: OEM tie-ups

Merck Animal Health: vertical integration

Key Anti-worm Medication Companies19 items

Bayer

Boehringer Ingelheim

Zoetis

Dechra

Chanelle Group

Merck Animal Health

Elanco

Virbac

Vetoquinol

GlaxoSmithKline

Huazhong Pharmaceutical

Jiangsu Qihui

Sequent Scientific

K.A. Malle Pharmaceuticals

Lasa Supergenics Limited

Zhongjia Pharmaceutical

Fredun Pharmaceuticals Ltd

Supharma Chem

Salius Pharma

Market Ecosystem

The Anti-worm Medication ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. This complex network creates and captures value through the development, manufacturing, and distribution of anti-worm medications. Understanding the Anti-worm Medication ecosystem is crucial for identifying key players, their roles, and the dynamics that shape the market.

Raw material/component suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce anti-worm medications

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer support and guidance

End users / buyers — purchase and administer anti-worm medications

Regulators/standards bodies — oversee safety and efficacy

Data/analytics providers — track usage and treatment outcomes

In the Anti-worm Medication ecosystem, control points are largely influenced by regulators and standards bodies, who enforce strict guidelines on safety, efficacy, and manufacturing practices. Dependency risks arise from input constraints, such as the availability of active pharmaceutical ingredients, and approvals from regulatory authorities. Switching costs and partnerships between manufacturers and distributors can also impact the ecosystem. Furthermore, the Anti-worm Medication ecosystem may differ by region due to varying standards, approval processes, and distribution channels, highlighting the need for a thorough value chain analysis to navigate these complexities.

Recent Industry Insights

The Anti-worm Medication industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between major pharmaceutical companies have led to the development of innovative treatments, while mergers and acquisitions have resulted in the expansion of product portfolios. Notably, several companies have launched new products and technologies, including improved formulations and delivery systems, to combat parasitic worm infections more effectively.

Additionally, regulatory changes have paved the way for faster approvals of anti-worm medications, and a shift in consumer trends towards preventative care has driven demand for these medications. Furthermore, funding rounds and expansions have enabled companies to invest in research and development, leading to a pipeline of promising new treatments. These developments are expected to shape the future of the Anti-worm Medication industry, driving growth and innovation in the years to come.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Anti-worm Medication market outlook. The market attractiveness is high due to the increasing prevalence of worm infections globally. The competitive intensity is moderate, with key players focusing on innovative formulations and distribution strategies. The long-term outlook is positive, driven by growing demand for effective treatments and rising healthcare expenditure. The innovation landscape is dynamic, with ongoing research into new compounds and delivery systems. The demand–supply balance is stable, with manufacturers adapting to changing market needs. Key risk factors include regulatory challenges and emerging resistance to existing treatments, which may impact market growth.

11 items

1. Executive Summary

2. Anti-worm Medication Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Anti-worm Medication Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Anti-worm Medication Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Human

6.1.2. Veterinary

6.2. Global Anti-worm Medication Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Albenza

6.2.2. Vermox

6.3. Global Anti-worm Medication Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Anti-worm Medication Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Anti-worm Medication Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Anti-worm Medication Market Competition by Key Manufacturers

8.1. Global Anti-worm Medication Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Anti-worm Medication: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Bayer

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Boehringer Ingelheim

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Zoetis

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Dechra

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Chanelle Group

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Merck Animal Health

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Elanco

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Virbac

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Vetoquinol

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. GlaxoSmithKline

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Huazhong Pharmaceutical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Jiangsu Qihui

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Sequent Scientific

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. K.A. Malle Pharmaceuticals

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Lasa Supergenics Limited

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Zhongjia Pharmaceutical

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Fredun Pharmaceuticals Ltd

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Supharma Chem

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Salius Pharma

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Anti-worm Medication Market

Figure 4: Global Anti-worm Medication Market: Drivers

Figure 5: Global Anti-worm Medication Market: Challenges

Figure 6: Global Anti-worm Medication Market: Trends

Figure 7: Global Anti-worm Medication Market: Opportunity

Figure 8: Global Anti-worm Medication Market: Restraint

Figure 9: Global Anti-worm Medication Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Anti-worm Medication Market Value (USD Million) By Region

Figure 15: Global Anti-worm Medication Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Anti-worm Medication Market Value (USD Million) By Region

Figure 23: Global Anti-worm Medication Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

91 items

Table 1: Market Segmentation Analysis

Table 2: Global Anti-worm Medication Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Anti-worm Medication Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Anti-worm Medication Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Anti-worm Medication Market Value (USD Million) By Region

Table 10: Global Anti-worm Medication Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Anti-worm Medication Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Anti-worm Medication Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Anti-worm Medication Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Bayer Basic Information And Sales Area

Table 31: Bayer. Products Portfolio

Table 32: Boehringer Ingelheim Basic Information And Sales Area

Table 33: Boehringer Ingelheim. Products Portfolio

Table 34: Zoetis Basic Information And Sales Area

Table 35: Zoetis. Products Portfolio

Table 36: Dechra Basic Information And Sales Area

Table 37: Dechra. Products Portfolio

Table 38: Chanelle Group Basic Information And Sales Area

Table 39: Chanelle Group. Products Portfolio

Table 40: Merck Animal Health Basic Information And Sales Area

Table 41: Merck Animal Health. Products Portfolio

Table 42: Elanco Basic Information And Sales Area

Table 43: Elanco. Products Portfolio

Table 44: Virbac Basic Information And Sales Area

Table 45: Virbac. Products Portfolio

Table 46: Vetoquinol Basic Information And Sales Area

Table 47: Vetoquinol. Products Portfolio

Table 48: GlaxoSmithKline Basic Information And Sales Area

Table 49: GlaxoSmithKline. Products Portfolio

Table 50: Huazhong Pharmaceutical Basic Information And Sales Area

Table 51: Huazhong Pharmaceutical. Products Portfolio

Table 52: Jiangsu Qihui Basic Information And Sales Area

Table 53: Jiangsu Qihui. Products Portfolio

Table 54: Sequent Scientific Basic Information And Sales Area

Table 55: Sequent Scientific. Products Portfolio

Table 56: K.A. Malle Pharmaceuticals Basic Information And Sales Area

Table 57: K.A. Malle Pharmaceuticals. Products Portfolio

Table 58: Lasa Supergenics Limited Basic Information And Sales Area

Table 59: Lasa Supergenics Limited. Products Portfolio

Table 60: Zhongjia Pharmaceutical Basic Information And Sales Area

Table 61: Zhongjia Pharmaceutical. Products Portfolio

Table 62: Fredun Pharmaceuticals Ltd Basic Information And Sales Area

Table 63: Fredun Pharmaceuticals Ltd. Products Portfolio

Table 64: Supharma Chem Basic Information And Sales Area

Table 65: Supharma Chem. Products Portfolio

Table 66: Salius Pharma Basic Information And Sales Area

Table 67: Salius Pharma. Products Portfolio

Table 68: Global Market Value (USD Million) (2025-2032) By Application

Table 69: Global Market Share (%) By Application (2032)

Table 70: Global Market Value (USD Million) (2025-2032) By Types

Table 71: Global Market Share (%) By Types (2032)

Table 72: Global Anti-worm Medication Market Value (USD Million) By Region

Table 73: Global Anti-worm Medication Market Share (%) By Region (2025-2032)

Table 74: North America Market Value (USD Million) (2025-2032) By Country

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: North America Market Value (USD Million) (2025-2032) By Types

Table 77: Europe Market Value (USD Million) (2025-2032) By Country

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Europe Market Value (USD Million) (2025-2032) By Types

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 83: South America Market Value (USD Million) (2025-2032) By Country

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: South America Market Value (USD Million) (2025-2032) By Types

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 89: Research Programs/Design For This Report

Table 90: Key Data Information From Secondary Sources

Table 91: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Anti-worm Medication Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bayer; Boehringer Ingelheim; Zoetis; Dechra; Chanelle Group; Merck Animal Health; Elanco; Virbac; Vetoquinol; GlaxoSmithKline; Huazhong Pharmaceutical; Jiangsu Qihui; Sequent Scientific; K.A. Malle Pharmaceuticals; Lasa Supergenics Limited; Zhongjia Pharmaceutical; Fredun Pharmaceuticals Ltd; Supharma Chem; Salius Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options